| Literature DB >> 27530747 |
Jeanette Wp Teo1, Ka Lip Chew1, Raymond Tp Lin1,2.
Abstract
Entities:
Mesh:
Substances:
Year: 2016 PMID: 27530747 PMCID: PMC5034101 DOI: 10.1038/emi.2016.85
Source DB: PubMed Journal: Emerg Microbes Infect ISSN: 2222-1751 Impact factor: 7.163
Characteristics of mcr-1-positive clinical Enterobacteriaceae isolates in Singapore
| NM12 | Urine | 11/01/2016 | ST460 | TEM-1 | Yes | Yes, ≈10−6 | 4 | 4 | ≤0.25 | ≤0.25 | ≤0.5 | ≤4 | ≤1 | ≥32 | 64 | 2 | 4 | <1 | <2 | |
| NM4 | Urine | 14/01/2016 | ST156 | TEM-1 | No | Yes, ≈10−7 | 4 | 4 | ≤0.25 | ≤0.25 | ≤0.5 | ≥64 | 16 | ≥32 | ≤4 | 1 | 2 | >16 | <2 | |
| NM2 | Urine | 13/01/2016 | ST1535 | TEM-1, CTX-M-15 | No | Yes, ≈10−3 | 24 | 8 | ≤0.25 | ≤0.25 | ≤0.5 | ≤4 | 16 | ≥32 | ≤4 | 1 | 2 | <1 | <2 | |
| Transconjugant NM12 | — | — | — | TEM-1 | — | — | 2 | 2 | ≤0.25 | ≤0.25 | ≤0.5 | ≤4 | ≤1 | ≥32 | 128 | 2 | 4 | ≤1 | ≤2 | |
| Transconjugant NM4 | — | — | — | TEM-1 | — | — | 4 | 6 | ≤0.25 | ≤0.25 | ≤0.5 | ≤64 | 16 | ≥32 | ≤4 | 1 | 2 | ≥16 | ≤2 | |
| Transconjugant NM2 | — | — | — | Not detected | — | — | 8 | 6 | ≤0.25 | ≤0.25 | ≤0.5 | ≤4 | ≤1 | 8 | ≤4 | ≤0.25 | ≤0.12 | ≤1 | ≤2 | |
| J53 | — | — | — | — | — | — | 0.5 | 0.25 | ≤0.25 | ≤0.25 | ≤0.5 | ≤4 | ≤1 | 8 | ≤4 | ≤0.25 | ≤0.12 | ≤1 | ≤2 | |
Abbreviations: amikacin, AMK; ampicillin, AMP; ceftazidime, CAZ; ciprofloxacin, CIP; colistin, COL; cefotaximase, CTX; ertapenem, ETP; cefoxitin, FOX; gentamicin, GEM; imipenem, IMP; levofloxacin, LEV; minimum inhibitory concentration, MIC; meropenem, MEM; polymyxin B, PB; piperacillin-tazobactam, PTZ.
The conjugation efficiency is calculated as the number of transconjugants per donor cell.
The interpretation of results of susceptibility testing were based on European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines. For colistin, a susceptible breakpoint of ≤2 mg/L and a resistant breakpoint of>2 mg/L was applied. Because no interpretative criteria are available for polymyxin B, colistin breakpoints were applied.
The Institut Pasteur MLST scheme was utilized. The following new allelic profile was obtained: dinB 22; pabB 21; putB 23; trpB 127; icdA 61; polB 109; trpA 41; uidA 164, and was assigned as ST460.